Legacy Financial Advisors’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.93M Buy
3,184
+35
+1% +$35.5K 0.41% 42
2025
Q4
$3.38M Buy
3,149
+141
+5% +$135K 0.47% 36
2025
Q3
$2.3M Sell
3,008
-156
-5% -$116K 0.32% 51
2025
Q2
$2.47M Buy
3,164
+129
+4% +$100K 0.39% 39
2025
Q1
$2.51M Buy
3,035
+81
+3% +$67.4K 0.42% 40
2024
Q4
$2.28M Sell
2,954
-62
-2% -$51.3K 0.38% 45
2024
Q3
$2.67M Buy
3,016
+68
+2% +$61.1K 0.45% 41
2024
Q2
$2.67M Buy
2,948
+44
+2% +$35.2K 0.48% 36
2024
Q1
$2.26M Buy
2,904
+97
+3% +$69K 0.4% 42
2023
Q4
$1.64M Buy
2,807
+154
+6% +$89.9K 0.31% 52
2023
Q3
$1.43M Buy
2,653
+21
+0.8% +$10.8K 0.29% 49
2023
Q2
$1.23M Sell
2,632
-88
-3% -$36.9K 0.23% 54
2023
Q1
$934K Sell
2,720
-304
-10% -$103K 0.19% 65
2022
Q4
$1.11M Buy
3,024
+1,223
+68% +$434K 0.24% 52
2022
Q3
$582K Buy
1,801
+46
+3% +$14.6K 0.14% 83
2022
Q2
$569K Buy
1,755
+143
+9% +$42.9K 0.14% 79
2022
Q1
$462K Buy
1,612
+81
+5% +$20.8K 0.1% 106
2021
Q4
$423K Buy
1,531
+148
+11% +$37.5K 0.1% 107
2021
Q3
$320K Sell
1,383
-172
-11% -$42.5K 0.08% 115
2021
Q2
$357K Buy
1,555
+148
+11% +$29.7K 0.09% 103
2021
Q1
$263K Sell
1,407
-28
-2% -$5.48K 0.07% 127
2020
Q4
$242K Sell
1,435
-9
-0.6% -$1.34K 0.07% 120
2020
Q3
$214K Buy
+1,444
New +$223K 0.07% 119
2019
Q2
Sell
-1,690
Closed -$219K 562
2019
Q1
$219K Buy
1,690
+128
+8% +$15.6K 0.07% 104
2018
Q4
$181K Buy
1,562
+389
+33% +$43.5K 0.07% 105
2018
Q3
$125K Hold
1,173
0.05% 146
2018
Q2
$105K Sell
1,173
-2,341
-67% -$192K 0.04% 165
2018
Q1
$278K Buy
3,514
+726
+26% +$58.4K 0.11% 83
2017
Q4
$235K Buy
+2,788
New +$237K 0.1% 98

Other funds holding LLY

Legacy Financial Advisors's LLY Position: Q1 2026 in Review

Legacy Financial Advisors increased its Eli Lilly (LLY) stake by 1.1% in Q1 2026, buying an estimated $35.5K and bringing the position to 3,184 shares worth $2.93M. The position accounts for 0.41% of the portfolio, ranked #42.

Legacy Financial Advisors first reported a position in LLY in Q4 2017 and has held it in 29 quarters since. The position peaked at $3.38M in Q4 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Legacy Financial Advisors held 3,184 shares of Eli Lilly worth $2.93M as of Q1 2026.
  • Legacy Financial Advisors bought 35 Eli Lilly shares in Q1 2026, an estimated $35.5K.
  • Eli Lilly made up 0.41% of Legacy Financial Advisors's portfolio in Q1 2026, its #42 holding.
  • Legacy Financial Advisors first reported a position in Eli Lilly in Q4 2017 and has held it in 29 quarters since.
  • Legacy Financial Advisors's Eli Lilly position peaked at $3.38M in Q4 2025.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Legacy Financial Advisors's 13F filing for Q1 2026, filed 30 Apr 2026.